Show summary Hide summary
This Saturday at Myriad Botanical Gardens in Oklahoma City, a one-mile walk will mark May’s Cystic Fibrosis Awareness Month, bringing families, clinicians and supporters together to raise funds for research and practical help for patients. Among those attending is Shelby Ballard, who is sharing her daughter Penny’s early diagnosis and daily treatment as a reminder of why continued investment in therapies matters now.
Ballard says Penny’s condition was discovered through routine newborn testing shortly after birth — a moment that reshaped the family’s expectations overnight. The diagnosis prompted quick connections with specialists at OU Children’s and the local cystic fibrosis clinic, which Ballard credits with helping the family navigate care and treatment.
A sudden diagnosis and cautious optimism
Penny’s parents learned she carries the genetic mutation that causes cystic fibrosis through the standard screening performed in the first days of life. Ballard describes the initial news as overwhelming; the family had little prior knowledge of the condition beyond dramatic portrayals in television dramas.
Olympic athletes bound for Oklahoma City University as campus readies for 2028 influx
Route 66 centennial: Oklahoma launches statewide festivities
Despite the early shock, Ballard emphasizes Penny’s current health: regular medical follow-ups and therapies have kept the child active and well, she says, though vigilance remains central to day-to-day life.
Daily routines and invisible burdens
Cystic fibrosis is an inherited disorder that thickens the body’s mucus, affecting the lungs and digestive system. For many children it means a strict regimen of medications and precautions to prevent infections that healthy immune systems clear more easily.
Ballard shared a striking visual at a recent interview — a container representing roughly a year’s supply of one of Penny’s medications. She explained that Penny takes digestive enzyme capsules with every meal and additional medicines each day to manage symptoms and maintain nutrition.
- When: Check-in at 9 a.m.; walk begins at 10 a.m. this Saturday.
- Where: Myriad Botanical Gardens, Oklahoma City.
- Purpose: Raise funds for research, clinical care and family support services.
- Local scale: Ballard notes there are roughly 400 people with cystic fibrosis in Oklahoma and about 40,000 nationwide who rely on ongoing advances in treatment.
For Penny, one of the daily medicines is Creon, an enzyme supplement that helps her digest food and absorb nutrients — functions that can be compromised by the thick mucus characteristic of the disease. Ballard described the logistics: multiple capsules at every meal plus several other medications administered across the day.
Why research remains urgent
Therapies known as modulators have transformed care for many patients in recent years, but they are not universally effective. Ballard points out that a minority of individuals with cystic fibrosis do not qualify for or do not respond to the current drugs, underscoring the continued need for new treatments and a true cure.
That gap is part of why families and local chapters organize community events — to fund patient services, support clinical trials and keep public attention on the condition’s realities. For caregivers, the practical and emotional costs of daily management are constant, even when a child appears healthy in public.
Ballard’s account is a reminder that early diagnosis and a coordinated care team can yield good outcomes today, but long-term improvement for all patients depends on sustained research and broader treatment options.
